Brokerages Set RTI Surgical Holdings Inc (NASDAQ:RTIX) Price Target at $3.63
Shares of RTI Surgical Holdings Inc (NASDAQ:RTIX) have been given an average rating of “Hold” by the six research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $3.63.
Several equities analysts have weighed in on RTIX shares. BidaskClub lowered RTI Surgical from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th. ValuEngine lowered RTI Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, April 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of RTI Surgical in a research report on Friday, April 17th. Finally, Zacks Investment Research raised RTI Surgical from a “hold” rating to a “buy” rating and set a $2.25 price target on the stock in a research report on Saturday, April 25th.
NASDAQ:RTIX opened at $2.14 on Wednesday. RTI Surgical has a 1-year low of $1.46 and a 1-year high of $5.40. The business’s 50-day moving average price is $2.08 and its two-hundred day moving average price is $2.77. The firm has a market capitalization of $169.04 million, a price-to-earnings ratio of -13.38 and a beta of 2.14.
About RTI Surgical
RTI Surgical Holdings, Inc, a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.
Recommended Story: Penny Stocks, What You Need To Know
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.